National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD) collection

The main purpose of the NOPSAD collection is to aggregate standardised jurisdictional data on the number of clients accessing pharmacotherapy for the treatment of opioid dependence, the number of prescribers participating in the delivery of pharmacotherapy treatment, and quantitative information about the prescribing sector. As such, national information on pharmacotherapy, on a snapshot day each year, can be reported.The collection covers the provision of opioid pharmacotherapy treatment, the practitioners who prescribe the treatment, the dosing sites who dispense the pharmacotherapy drugs, and the clients receiving the opioid pharmacotherapy treatment. The following pharmacotherapies are currently recommended for the treatment of opioid dependency: Methadone hydrochloride Methadone Syrup®, Biodone Forte ® Buprenorphine Subutex® Buprenorphine/ Naloxone Suboxone®, buprenorphine as long acting injections (Buvidal® and Sublocade®).